Search results
Results from the WOW.Com Content Network
Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [6] [7] It was developed by Biogen and Eisai. [8]
Let's do our part as a community to spread awareness and fundraise, by walking and dancing at the upcoming November Alzheimer’s Association events
An estimated 6.7 million Americans ages 65 and older were living with Alzheimer’s in 2023, according to the Alzheimer’s Association. The number is projected to increase to 13.8 million by 2060.
The Alzheimer’s Society notes that people living with dementia tend to have sleep issues, but the evidence is currently unclear on whether poor sleep is a risk factor for the disease.
These allegations involved crucial studies related to Alzheimer's and Parkinson's disease, particularly surrounding the alpha-synuclein protein. [ 1 ] The dossier was sent to the HHS Office of Research Integrity , which requested that the National Institute on Aging (NIA) start a research misconduct investigation in May 2023. [ 11 ]
Smith served on the Professional Advisory Board of the Cleveland chapter of the Alzheimer's Association and was Team Captain of a group of local researchers ("A Cure From Cleveland") that participates in the annual fund raising Memory Walk for the Alzheimer's Association. In addition, Smith donated his time as a frequent guest speaker at local ...
For premium support please call: 800-290-4726 more ways to reach us
Science says it was the fifth-highest cited paper in Alzheimer's research as of early 2022, with approximately 2,300 other articles citing it. [12] The Guardian says the paper was "highly influential" and calls it "one of the most cited pieces of Alzheimer's disease research in the last two decades", writing that it has "dominated the field" of ...